| Edward P Kaplan, MD | |
|
7777 Forest Ln, Ste A230, Dallas, TX 75230-2598 | |
| (972) 566-7765 | |
| (972) 566-4656 |
| Full Name | Edward P Kaplan |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 33 Years |
| Location | 7777 Forest Ln, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164418133 | NPI | - | NPPES |
| 144157805 | Other | TX | MEDICAID OTHER |
| 144157802 | Medicaid | TX | |
| 144157806 | Medicaid | TX | |
| 144157803 | Medicaid | TX | |
| 144157804 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | J2120 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Clinics Of North Texas, Pllc | 5496736415 | 68 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
A study from the microbiology lab at Rhode Island Hospital has found that a new test may be more accurate in identifying a common sexually transmitted infection, Trichamonos vaginalis.
The final agenda is now available online for the Complex PCI: Left Main and CTO Summit at http://www.complexpci.com/conference/agenda.html. The Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
About 3% of colorectal cancers are due to Lynch syndrome, an inherited cancer susceptibility syndrome that predisposes individuals to various cancers. Close blood relatives of patients with Lynch syndrome have a 50% chance of inheritance. The role that PMS2 genetic mutations play in Lynch syndrome has been underestimated in part due to technological limitations.
› Verified 1 days ago
| Entity Name | Urology Clinics Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780971549 PECOS PAC ID: 5496736415 Enrollment ID: O20040526000711 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
A study from the microbiology lab at Rhode Island Hospital has found that a new test may be more accurate in identifying a common sexually transmitted infection, Trichamonos vaginalis.
The final agenda is now available online for the Complex PCI: Left Main and CTO Summit at http://www.complexpci.com/conference/agenda.html. The Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
About 3% of colorectal cancers are due to Lynch syndrome, an inherited cancer susceptibility syndrome that predisposes individuals to various cancers. Close blood relatives of patients with Lynch syndrome have a 50% chance of inheritance. The role that PMS2 genetic mutations play in Lynch syndrome has been underestimated in part due to technological limitations.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward P Kaplan, MD 7777 Forest Ln, Ste A230, Dallas, TX 75230-2568 Ph: (214) 692-8262 | Edward P Kaplan, MD 7777 Forest Ln, Ste A230, Dallas, TX 75230-2598 Ph: (972) 566-7765 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
A study from the microbiology lab at Rhode Island Hospital has found that a new test may be more accurate in identifying a common sexually transmitted infection, Trichamonos vaginalis.
The final agenda is now available online for the Complex PCI: Left Main and CTO Summit at http://www.complexpci.com/conference/agenda.html. The Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
About 3% of colorectal cancers are due to Lynch syndrome, an inherited cancer susceptibility syndrome that predisposes individuals to various cancers. Close blood relatives of patients with Lynch syndrome have a 50% chance of inheritance. The role that PMS2 genetic mutations play in Lynch syndrome has been underestimated in part due to technological limitations.
› Verified 1 days ago
Dr. Xiaosong Meng, M.D., PH.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 | |
Bruce Jeremy Schlomer, MD Urology Medicare: Medicare Enrolled Practice Location: 2350 N Stemmons Fwy, Suite D-4300, Mc F4.04, Dallas, TX 75207 Phone: 214-456-2444 | |
Dr. Jodi Antonelli, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-5615 Fax: 214-648-8786 | |
Dr. Eric Bryan Smith, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3417 Gaston Ave, Ste 830, Dallas, TX 75246 Phone: 214-826-6235 Fax: 214-828-4633 | |
Gary Evan Lemack, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8765 | |
Dr. Homa Jackson Porter Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8230 Walnut Hill Ln, Suite 700, Dallas, TX 75231 Phone: 214-691-1902 Fax: 214-987-1845 | |
Dr. Michelle Leigh Mcdonald, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |